Genetec Corp. (JP:4492)
:4492
Top Page
Genetec Corp.
(4492)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥501.00
▲(4.59% Upside)
Action:DowngradedDate:03/24/26
The score is driven primarily by improving fundamentals (strong growth and a profitability rebound), tempered by higher 2025 leverage and still-inconsistent cash-flow performance. Valuation is supportive with a moderate P/E and strong dividend yield, while technicals are mixed with near-term weakness and an overbought stochastic signal.
Positive Factors
Revenue growth trend
Multi-year top-line expansion from 2022–2025 indicates durable demand and successful product adoption. Sustained revenue growth supports scale, enables reinvestment in R&D and sales, and reduces reliance on one-off gains, improving visibility for 2–6 month+ planning horizons.
Negative Factors
Rising leverage
A sharp increase in debt and a debt-to-equity near 1.0 materially reduces financial flexibility and raises fixed interest burdens. This heightened leverage amplifies downside risk from any future earnings slowdown and constrains strategic choices over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth trend
Multi-year top-line expansion from 2022–2025 indicates durable demand and successful product adoption. Sustained revenue growth supports scale, enables reinvestment in R&D and sales, and reduces reliance on one-off gains, improving visibility for 2–6 month+ planning horizons.
Read all positive factors
Genetec Corp. (4492) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.42B
Dividend Yield4.06%
Average Volume (3M)20.16K
Price to Earnings (P/E)14.3
Beta (1Y)0.56
Revenue Growth15.79%
EPS Growth-33.67%
CountryJP
Employees347
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)8.39
Shares Outstanding11,727,700
10 Day Avg. Volume14,300
30 Day Avg. Volume20,160
Financial Highlights & Ratios
PEG Ratio14.41
Price to Book (P/B)2.49
Price to Sales (P/S)0.74
P/FCF Ratio15.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genetec Corp. Business Overview & Revenue Model
Company Description
Genetec Corporation engages in software development business in Japan. The company operates through three segments: Digital Solutions Business, Engineering Solutions Business, and Cocodayo Business. It provides system solutions that offers embedde...
How the Company Makes Money
null...
Genetec Corp. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
58
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.60B | 8.12B | 7.15B | 5.86B | 4.68B | 4.08B |
| Gross Profit | 3.37B | 3.27B | 2.91B | 2.32B | 1.96B | 1.56B |
| EBITDA | 739.33M | 849.75M | 775.92M | 259.62M | 226.31M | 279.28M |
| Net Income | 385.77M | 421.12M | 414.77M | 23.76M | 56.64M | 173.41M |
Balance Sheet | ||||||
| Total Assets | 6.80B | 7.15B | 4.52B | 4.12B | 3.25B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 1.92B | 1.99B | 1.17B | 1.08B | 1.04B | 1.48B |
| Total Debt | 2.28B | 2.26B | 640.00M | 976.09M | 50.62M | 75.00M |
| Total Liabilities | 4.49B | 4.75B | 2.31B | 2.26B | 1.39B | 1.02B |
| Stockholders Equity | 2.31B | 2.40B | 2.21B | 1.87B | 1.86B | 1.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 384.76M | 578.85M | -322.73M | -117.29M | 424.00M |
| Operating Cash Flow | 0.00 | 451.42M | 602.37M | -223.12M | -24.03M | 443.26M |
| Investing Cash Flow | 0.00 | -388.73M | -55.73M | -439.20M | -98.15M | -38.53M |
| Financing Cash Flow | 0.00 | 655.92M | -410.02M | 714.93M | -94.71M | -76.04M |
Genetec Corp. Technical Analysis
Negative
479.00
Price Trends
478.16
Negative
467.39
Negative
468.13
Negative
Market Momentum
0.47
Positive
39.03
Neutral
30.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Negative. The current price of 479 is below the 20-day moving average (MA) of 480.35, above the 50-day MA of 478.16, and above the 200-day MA of 468.13, indicating a bearish trend. The MACD of 0.47 indicates Positive momentum. The RSI at 39.03 is Neutral, neither overbought nor oversold. The STOCH value of 30.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4492.
Genetec Corp. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥5.83B | 10.91 | ― | 1.87% | 6.18% | 29.79% | |
71 Outperform | ¥4.79B | 21.99 | ― | ― | 7.60% | 19.13% | |
64 Neutral | ¥5.42B | 14.30 | ― | 4.06% | 15.79% | -33.67% | |
63 Neutral | ¥4.74B | 9.17 | ― | 2.28% | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥6.64B | 27.15 | ― | ― | 11.32% | ― | |
47 Neutral | ¥4.41B | -18.61 | ― | ― | -40.57% | 83.14% |
* Technology Sector Average
JP:4492
Genetec Corp.
466.00
-58.70
-11.19%
JP:3826
System Integrator Corp.
437.00
74.89
20.68%
JP:4397
TeamSpirit, Inc.
411.00
-29.00
-6.59%
JP:4491
Computer Management Co., Ltd.
2,925.00
1,300.15
80.02%
JP:5033
Nulab Inc.
732.00
-366.00
-33.33%
JP:7527
SystemSoft Corporation
52.00
-28.00
-35.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.